Trial intelligence / Profile preview

Simvastatin for steroid reduction in sight-threatening uveitis

NCT02252328Phase 3Unknown

Sponsor
University College London
Start
Sep 2015
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in uveitis, sponsored by University College London. Status: unknown.

02

Drugs

simvastatin
03

Conditions

uveitis

Beyond the preview

Go deeper on NCT02252328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02252328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call